SOLON, Ohio—Saint-Gobain Life Sciences purchased Pompey, France-based MS Techniques and Transluminal effective Sept. 7.
The MS Techniques facility will be the foundation of Saint-Gobain's new European Medical Center for Excellence, Vanessa Gagnon, commercial director of catheter systems at Saint-Gobain, told Plastics News.
"This will be our first site fully dedicated to the medical industry in Europe," Gagnon said.
Gagnon, who led the acquisition process, is working to develop the global commercial strategy for the integration of MS Techniques, a high-precision thermoplastic extruder, into Saint-Gobain Life Sciences' Medical Components business unit, she said.
(MS Techniques) "has capabilities that Saint-Gobain has been looking to acquire organically for a while now," Gagnon said. "We're seeing two major trends in the medical device industry: One is the supply chain consolidation, and two is the shift to a value-based reimbursement system."
MS Techniques also brings to Saint-Gobain design expertise for minimally invasive procedures through catheter technology, she said.
"We wanted to have a broader product portfolio and offer more to our customers," Gagnon said. MS Techniques "think(s) outside the box and find(s) ways to design new delivery systems that enables better outcome ultimately at a lower cost. ... We're looking forward to expanding their sales reach from their Europe base to provide such product to the U.S. and Asian markets."
"We decided to join forces with Saint-Gobain because we felt we found a true partnership and shared the same vision: to become a world-class reference in the medical device industry for delivering minimally invasive innovation," Etienne Malher, president of MS Techniques, said in a Sept. 14 news release.